+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Follicular Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sezary Syndrome - Pipeline Insghts, 2025 - Product Thumbnail Image

Sezary Syndrome - Pipeline Insghts, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
CXCR4 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

CXCR4 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Chronic Myeloid Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Myeloid Leukemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Osteosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gallbladder Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Gallbladder Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Synovial Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Synovial Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Recurrent Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2025 - Product Thumbnail Image

Peritoneal Carcinomatosis (PC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Central Nervous System Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Central Nervous System Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more